{"version":"https://jsonfeed.org/version/1","title":"Micro.blog - Slimchecker","home_page_url":"https://micro.blog","feed_url":"https://micro.blog/posts/slimchecker","_microblog":{"about":"https://micro.blog/about/api","id":"1911202","username":"slimchecker","bio":"Once dismissed by some as a shortcut, Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a powerful tool in treating obesity as a chronic disease. With the World Health Organization (WHO) issuing its first global guidelines on their use, we are entering a new era of metabolic medicine","pronouns":"","is_following":false,"is_you":false,"following_count":1,"discover_count":0},"author":{"name":"Slimchecker","url":"https://slimchecker.com/","avatar":"https://www.gravatar.com/avatar/d46bd2b534d91f3d5a024f2d066353c1?s=96&d=https%3A%2F%2Fmicro.blog%2Fimages%2Fblank_avatar.png"},"items":[]}